⚠️✴️ #акции #трейдинг
Windtree Therapeutics (WINT) — a biotech company that decided to copy MicroStrategy's strategy, but with an emphasis on BNB, has started to buy the token for its corporate balance.
However, Nasdaq sent a notice of non-compliance with listing requirements: shares #WINT have been trading below $1 for too long. Delisting and transitioning to the over-the-counter market is likely.
On the news, the stocks plummeted by -77%, despite the fact that #BNB today reached a historical maximum.
Betting on the growth of crypto through "penny stocks" carries additional risks — the example of WINT has shown this.